FDA Inspection 1061630 — Northern Illinois Blood Bank

Northern Illinois Blood Bank — FEI 1475219

The FDA completed an inspection of Northern Illinois Blood Bank on Jul 26, 2018 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rockford, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.